Basic 2-year cohort demographics and office visit data.

<p>Basic 2-year cohort demographics and office visit data.</p

2-year cohort data on treatment types and frequencies.

<p>2-year cohort data on treatment types and frequencies.</p

Flow chart for inclusion/exclusion criteria for each of the final cohorts.

<p>*Diagnoses included proliferative retinopathies, sickle cell disease, vein occlusions, pathologic myopia, retinoschisis, age-related macular degeneration, cystoid macular edema, all uveitides, glaucoma and intraocular surgery within 90 days of index date. **Diagnoses included proliferative retinopathies, sickle cell disease, vein occlusions, pathologic myopia, retinoschisis, age-related macular degeneration, cystoid macular edema, all uveitides, and glaucoma.</p

Data on ancillary study types and frequencies in the 2-year cohorts.

<p>Data on ancillary study types and frequencies in the 2-year cohorts.</p

1-year cohort data on office visits, treatment types and frequencies.

<p>1-year cohort data on office visits, treatment types and frequencies.</p

ICD-9, CPT and Drug codes used in this study.

<p>ICD-9, CPT and Drug codes used in this study.</p